Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.
about
Changes in the Factor VIII C2 domain upon membrane binding determined by hydrogen-deuterium exchange MS.Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.X-linked juvenile retinoschisis: clinical diagnosis, genetic analysis, and molecular mechanisms.High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors.Pathogenesis and Management of Acquired Haemophilia.Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
P2860
Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Characterization of an acquire ...... ralizes procoagulant activity.
@ast
Characterization of an acquire ...... ralizes procoagulant activity.
@en
type
label
Characterization of an acquire ...... ralizes procoagulant activity.
@ast
Characterization of an acquire ...... ralizes procoagulant activity.
@en
prefLabel
Characterization of an acquire ...... ralizes procoagulant activity.
@ast
Characterization of an acquire ...... ralizes procoagulant activity.
@en
P2093
P2860
P356
P1476
Characterization of an acquire ...... ralizes procoagulant activity.
@en
P2093
D Devore-Carter
L A Charles
M A Quinn-Allen
P2860
P304
P356
10.1172/JCI116123
P407
P577
1992-12-01T00:00:00Z